Michael Anstey is Director at BICYCLE THERAPEUTICS plc (BCYC). They have made 1 open-market trade across 1 company since 2019, most recently 2019-05-28.
CIK 0001776856
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.4M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCYC | 1,437,151 | $5.0M |
Shares reported on the most recent Form 4, priced at the 2019-05-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCYC | BUY | 2019-05-28 | 2019-05-30 | $14.00 | $4.4M | +0.0% | -16.8% | -43.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.